102 related articles for article (PubMed ID: 22116519)
1. Molecular pathogenesis of pancreatic cancer and clinical perspectives.
Matthaios D; Zarogoulidis P; Balgouranidou I; Chatzaki E; Kakolyris S
Oncology; 2011; 81(3-4):259-72. PubMed ID: 22116519
[TBL] [Abstract][Full Text] [Related]
2. Molecular target-based therapy of pancreatic cancer.
Lebedeva IV; Sarkar D; Su ZZ; Gopalkrishnan RV; Athar M; Randolph A; Valerie K; Dent P; Fisher PB
Cancer Res; 2006 Feb; 66(4):2403-13. PubMed ID: 16489047
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of pancreatic cancer.
Maitra A; Kern SE; Hruban RH
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
[TBL] [Abstract][Full Text] [Related]
4. Molecular aspects of carcinogenesis in pancreatic cancer.
Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability.
Yamamoto H; Itoh F; Nakamura H; Fukushima H; Sasaki S; Perucho M; Imai K
Cancer Res; 2001 Apr; 61(7):3139-44. PubMed ID: 11306499
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Talar-Wojnarowska R; Malecka-Panas E
Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
[TBL] [Abstract][Full Text] [Related]
7. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs in the treatment of pancreatic cancer.
Mahalingam D; Kelly KR; Swords RT; Carew J; Nawrocki ST; Giles FJ
Expert Opin Emerg Drugs; 2009 Jun; 14(2):311-28. PubMed ID: 19466902
[TBL] [Abstract][Full Text] [Related]
9. Biologic therapies for advanced pancreatic cancer.
He AR; Lindenberg AP; Marshall JL
Expert Rev Anticancer Ther; 2008 Aug; 8(8):1331-8. PubMed ID: 18699769
[TBL] [Abstract][Full Text] [Related]
10. The Smad family and its role in pancreatic cancer.
Singh P; Wig JD; Srinivasan R
Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
[TBL] [Abstract][Full Text] [Related]
11. New treatment options for advanced pancreatic cancer.
Middleton G; Ghaneh P; Costello E; Greenhalf W; Neoptolemos JP
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):673-96. PubMed ID: 19072345
[TBL] [Abstract][Full Text] [Related]
12. [TGF-beta signaling pathway in pancreatic cancer cells].
Ijichi H
Nihon Rinsho; 2004 Jul; 62(7):1241-8. PubMed ID: 15283139
[TBL] [Abstract][Full Text] [Related]
13. Killer genes in pancreatic cancer therapy.
Fogar P; Greco E; Basso D; Navaglia F; Plebani M; Pedrazzoli S
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):61-76. PubMed ID: 16171565
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeting therapy for pancreatic cancer.
Xiong HQ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S69-77. PubMed ID: 15316751
[TBL] [Abstract][Full Text] [Related]
15. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
16. Agents targeting the Hedgehog pathway for pancreatic cancer treatment.
Bisht S; Brossart P; Maitra A; Feldmann G
Curr Opin Investig Drugs; 2010 Dec; 11(12):1387-98. PubMed ID: 21154121
[TBL] [Abstract][Full Text] [Related]
17. Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
Vaccaro V; Melisi D; Bria E; Cuppone F; Ciuffreda L; Pino MS; Gelibter A; Tortora G; Cognetti F; Milella M
Expert Opin Ther Targets; 2011 Oct; 15(10):1183-96. PubMed ID: 21819318
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
[TBL] [Abstract][Full Text] [Related]
19. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
